Unlisted
| Company Name | (주)아미노로직스 |
| English Name | AMINOLOGICS CO.,LTD. |
| Business Reg. No. | 1298123337 |
| CEO | 오장석,오성석 |
| Address | 서울특별시 강남구 역삼로 151 삼오빌딩3층 301호 |
| Industry | 의약품 도매업 |
| Industry Code | 46441 |
| Established | Contact |
| Phone | 02-761-4570 |
| Website | www.aminologics.co.kr |
| Regular Employees | 40persons |
| Corp. Reg. No. | 1311110030369 |
Venture Certified
| 연구개발기업 | 1999-05-07 ~ 2000-12-31 | 1999162521-0653 | 1999-05-07 |
| 연구개발기업 | 2001-08-10 ~ 2003-08-09 | 011629021203472 | 1999-05-07 |
| 연구개발기업 | 2003-08-10 ~ 2005-08-09 | 031626131300580 | 1999-05-07 |
| 연구개발기업 | 2005-08-10 ~ 2007-08-09 | 051626121400996 | 1999-05-07 |
| 연구개발유형 | 2007-08-10 ~ 2009-08-09 | 20070102570 | 1999-05-07 |
| 연구개발유형 | 2009-08-10 ~ 2011-08-09 | 20090106543 | 1999-05-07 |
| 연구개발유형 | 2011-08-10 ~ 2013-08-09 | 20110104706 | 1999-05-07 |
| 연구개발유형 | 2013-08-10 ~ 2015-08-09 | 20130107501 | 1999-05-07 |
| 연구개발유형 | 2015-08-10 ~ 2017-08-09 | 20150108126 | 1999-05-07 |
| 연구개발유형 | 2017-11-03 ~ 2019-11-02 | 20170112765 | 1999-05-07 |
| 연구개발유형 | 2019-11-03 ~ 2021-11-02 | 20190112665 | 1999-05-07 |
| 연구개발유형 | 2021-11-03 ~ 2024-11-02 | 20211104020004 | 1999-05-07 |
| 연구개발유형 | 2024-11-03 ~ 2027-11-02 | 20241120020014 | 1999-05-07 |
Revenue CAGR -21.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 168B | 209B | 273B |
| Operating Profit | -22B | 15B | 70B |
| Net Profit | -11B | 23B | -63B |
| Total Assets | 568B | 577B | 556B |
| Total Liabilities | 51B | 33B | 42B |
| Total Equity | 517B | 544B | 514B |
Operating Loss: Op. profit -22B
Debt Ratio Surge (+4pp YoY)
▼ 30.4%
▼ 150.7%
▼ 178.4%
▲ 39.7%
▲ 46.6%
| Name | Position | Role |
|---|---|---|
| 오장석,오성석 | 대표이사 | 대표 |
| NPS Subscribers | 40persons |
| CEO | 오장석,오성석 |
| Est. Avg. Annual Salary | 5,48510K (45710K/mo) |
| Hired (12 mo) | +1persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | +1persons |
| NPS Join Date | 1997-10-28 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 신규 중간체 및 이를 이용하는 H-AEEA-AEEA-OH의 제조방법 | 주식회사 아미노로직스 | 1020250097490 | 2025-07-18 | 공개 |
| 모노-터트-부틸 에스터화된 포화 탄화수소의 제조방법 및 이의 순환적 제조방법 | 주식회사 아미노로직스 | 1020230060347 | 2023-05-10 | 공개 |
| 광학 활성을 가진 2-옥틸글리신 에스터를 제조하는 방법 | 주식회사 아미노로직스 | 1020170170315 | 2017-12-12 | 소멸 |
| DL-4,4'-바이페닐알라닌 알킬에스터로부터 D-4,4'-바이페닐알라닌 알킬에스터 또는 L-4,4'-바이페닐알라닌 알킬에스터를 제조하는 방법 | 주식회사 아미노로직스 | 1020160047462 | 2016-04-19 | 거절 |
| 아미노벤즈알데히드 유도체 및 이를 포함하는 아미노산 키랄 추출제 | 주식회사 아미노로직스|이화여자대학교 산학협력단 | 1020150177313 | 2015-12-11 | 포기 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 강남구 역삼로",
"brno": "129812****",
"cappedWarning": false,
"companyName": "(주)아미노로직스",
"estimatedAvgAnnualSalary": 54851868,
"estimatedAvgMonthlySalary": 4570989,
"fetchedAt": "2026-03-05T18:52:03.985Z",
"industryCode": "321000",
"industryName": "기타 반도체 소자 제조업",
"joinDate": "19971028",
"last12MonthsHired": 1,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 1,
"leaveDate": null,
"monthlyPensionAmount": 17369760,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 1,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6407106",
"status": "1",
"styleCode": "1",
"subscriberCount": 40,
"turnoverMonths": 1
}{
"address": "서울특별시 강남구",
"ceo_name": "오장석, 오성석",
"certificate": [
{
"cert_number": "1999162521-0653",
"changes": "",
"disclosure_date": "1999-05-07",
"first_cert_date": "1999-05-07",
"no": "1",
"type": "연구개발기업",
"valid_period": "1999-05-07 ~ 2000-12-31"
},
{
"cert_number": "011629021203472",
"changes": "",
"disclosure_date": "2001-08-10",
"first_cert_date": "1999-05-07",
"no": "2",
"type": "연구개발기업",
"valid_period": "2001-08-10 ~ 2003-08-09"
},
{
"cert_number": "031626131300580",
"changes": "",
"disclosure_date": "2003-08-10",
"first_cert_date": "1999-05-07",
"no": "3",
"type": "연구개발기업",
"valid_period": "2003-08-10 ~ 2005-08-09"
},
{
"cert_number": "051626121400996",
"changes": "",
"disclosure_date": "2005-08-10",
"first_cert_date": "1999-05-07",
"no": "4",
"type": "연구개발기업",
"valid_period": "2005-08-10 ~ 2007-08-09"
},
{
"cert_number": "20070102570",
"changes": "",
"disclosure_date": "2007-08-09",
"first_cert_date": "1999-05-07",
"no": "5",
"type": "연구개발유형",
"valid_period": "2007-08-10 ~ 2009-08-09"
},
{
"cert_number": "20090106543",
"changes": "",
"disclosure_date": "2009-07-03",
"first_cert_date": "1999-05-07",
"no": "6",
"type": "연구개발유형",
"valid_period": "2009-08-10 ~ 2011-08-09"
},
{
"cert_number": "20110104706",
"changes": "",
"disclosure_date": "2011-07-26",
"first_cert_date": "1999-05-07",
"no": "7",
"type": "연구개발유형",
"valid_period": "2011-08-10 ~ 2013-08-09"
},
{
"cert_number": "20130107501",
"changes": "",
"disclosure_date": "2013-07-22",
"first_cert_date": "1999-05-07",
"no": "8",
"type": "연구개발유형",
"valid_period": "2013-08-10 ~ 2015-08-09"
},
{
"cert_number": "20150108126",
"changes": "",
"disclosure_date": "2015-08-05",
"first_cert_date": "1999-05-07",
"no": "9",
"type": "연구개발유형",
"valid_period": "2015-08-10 ~ 2017-08-09"
},
{
"cert_number": "20170112765",
"changes": "",
"disclosure_date": "2017-11-03",
"first_cert_date": "1999-05-07",
"no": "10",
"type": "연구개발유형",
"valid_period": "2017-11-03 ~ 2019-11-02"
},
{
"cert_number": "20190112665",
"changes": "",
"disclosure_date": "2019-10-31",
"first_cert_date": "1999-05-07",
"no": "11",
"type": "연구개발유형",
"valid_period": "2019-11-03 ~ 2021-11-02"
},
{
"cert_number": "20211104020004",
"changes": "",
"disclosure_date": "2021-11-04",
"first_cert_date": "1999-05-07",
"no": "12",
"type": "연구개발유형",
"valid_period": "2021-11-03 ~ 2024-11-02"
},
{
"cert_number": "20241120020014",
"changes": "",
"disclosure_date": "2024-11-20",
"first_cert_date": "1999-05-07",
"no": "13",
"type": "연구개발유형",
"valid_period": "2024-11-03 ~ 2027-11-02"
}
],
"company_name": "㈜아미노로직스",
"financials": {
"2022": {
"capital_stock": 8782684000,
"cost_of_sales": 14528867000,
"current_assets": 43567648000,
"current_liabilities": 3423997000,
"gross_profit": 12808061000,
"net_income": -6280725000,
"net_income_bs": -7281575000,
"non_current_assets": 12013104000,
"non_current_liabilities": 749491000,
"non_operating_expenses": 15272206000,
"non_operating_income": 1956836000,
"operating_profit": 7034645000,
"revenue": 27336928000,
"sga_expenses": 5773416000,
"total_assets": 55580752000,
"total_equity": 51407264000,
"total_liabilities": 4173488000
},
"2023": {
"capital_stock": 8782684000,
"cost_of_sales": 13110991000,
"current_assets": 45247398000,
"current_liabilities": 2662843000,
"gross_profit": 7775632000,
"net_income": 2290868000,
"net_income_bs": 2436181000,
"non_current_assets": 12419232000,
"non_current_liabilities": 589535000,
"non_operating_expenses": 652791000,
"non_operating_income": 1481643000,
"operating_profit": 1462016000,
"revenue": 20886623000,
"sga_expenses": 6313616000,
"total_assets": 57666630000,
"total_equity": 54414252000,
"total_liabilities": 3252378000
},
"2024": {
"capital_stock": 8782684000,
"cost_of_sales": 13371553000,
"current_assets": 46515682000,
"current_liabilities": 4336609000,
"gross_profit": 3418720000,
"net_income": -1104432000,
"net_income_bs": -1619873000,
"non_current_assets": 10271988000,
"non_current_liabilities": 734769000,
"non_operating_expenses": 1175802000,
"non_operating_income": 2224418000,
"operating_profit": -2153048000,
"revenue": 16790273000,
"sga_expenses": 5571768000,
"total_assets": 56787670000,
"total_equity": 51699177000,
"total_liabilities": 5088493000
}
},
"industry": "의약품 도매업",
"investment": [],
"phone": "02-761-****",
"source": "pg_migration"
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| Venture System Detail | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |